corruption
and conflicts of interest

The term "revolving door" refers to the movement of high-level employees from public sector jobs to private sector jobs, and vice versa. The idea is that there is a revolving door between the two sectors as many legislators and regulators become lobbyists and consultants for the industries they once regulated and some private industry heads or lobbyists receive government appointments that relate to their former private posts.

If this is alarming to you, you're not alone. What's worse is that every single FDA commissioner except ONE has gone on to work with or join the board of a pharmaceutical company after leaving the agency. 

Scott Gottlieb was FDA commissioner from May 2017 until he left in April of 2019 to sit on the board of pharmaceutical company and vaccine manufacturer Pfizer. He now profits from a company he was regulating a mere 3 months prior to his move. 

Robert Califf, FDA Commissioner from February of 2016 to January 2017, was a consultant for the pharmaceutical industry. His clients included Merck, AstraZeneca, Eli Lilly, and Johnson & Johnson. Following his tenure as commissioner, he took a job with pharma company Biokinetics.

Margaret Hamburg became commissioner in 2009 and was charged in a racketeering lawsuit shortly after she left office. After stepping down, she took a job with Alnylam Pharmaceuticals. 

Andrew Von Eschenbach was commissioner from 2006-2009. After leaving his post he took on a position with BioTime, a biotechnology company that works with developing stem cell therapies and cancer drugs. 

Lester Crawford only served a few months before resigning in the midst of allegations that he did not disclose conflicts of interest. He later pled guilty and was given 3 years probation and a fine. He then joined Policy Directions who represents Merck, Nestle, and Alpharma Inc. 

Mark McClellan served as commissioner from 2002-2004 who then went on to work for Johnson & Johnson. 

Jane Henney was commissioner from 1998-2001 and left to become director of Amerisourcebergen Corp, a wholesale drug company.

 

CDC

Dr. Julie Gerberding was director of the CDC from 2002-2009 (during which the fraudulent MMR-Autism "study" was conducted). She left her position there to become head of Merck's vaccine division, responsible for the commercialization of the current portfolio of vaccines, planning for the introduction of vaccines from the company's robust vaccine pipeline, and accelerating Merck's on-going efforts to broaden access to its vaccines in the developing world

The corruption surrounding vaccines doesn't end with our regulatory agencies. Media outlets receive funding from pharmaceutical companies which results in the truth being withheld from the public and the same lines being repeated verbatim that vaccines are "safe and effective". 

Doctors and medical professionals also receive educational materials that are produced by these companies and vaccine manufacturers. The universities they attend receive funding from them. Insurance companies have cozy deals with these companies to offer incentives like kickbacks to doctors for selling these products. 

This kind of corruption leads to the polarization we see now. Parents against parents. Doctors against mothers. Politicians forcing harmful legislation. The sooner we bring this information to light for families around the nation, the sooner we can demand change. 

Sign up for our e-mail newsletters!
Connect With Us:
  • Facebook
  • Instagram
  • Twitter
Donate: